Table 3.
Model | Men | Women | ||
---|---|---|---|---|
Hazards ratio (95% CI) | P | Hazards ratio (95% CI) | P | |
Plasma CETPb as a continuous variable, adjusted for baseline risk factorsa | 0.79 (0.64, 0.98) | 0.032 | 1.01 (0.81, 1.27) | 0.914 |
Plasma CETPb as a continuous variable, adjusted for baseline risk factorsa and PLTP | 0.80 (0.65, 0.99) | 0.036 | 1.01 (0.81, 1.27) | 0.920 |
Plasma CETP activity as a binary variable, adjusted for baseline risk factorsa and PLTP; hazards ratio for CETP activity ≥median (<median as referent) | 0.64 (0.43, 0.95) | 0.026 | 0.94 (0.59, 1.49) | 0.789 |
Plasma PLTPb as a continuous variable, adjusted for baseline risk factorsa | 1.20 (1.00, 1.45) | 0.046 | 1.03 (0.81, 1.32) | 0.796 |
Plasma PLTPb as a continuous variable, adjusted for baseline risk factorsa and CETP | 1.20 (1.00, 1.44) | 0.052 | 1.03 (0.81, 1.32) | 0.799 |
Plasma PLTP activity as a binary variable, adjusted for baseline risk factorsa and CETP; Hazards Ratio for CETP activity ≥median (<median as referent) | 1.64 (1.10, 2.46) | 0.016 | 0.95 (0.60, 1.51) | 0.838 |
CETP/PLTP activity ratiob | 0.66 (0.51, 0.87) | 0.003 | 0.97 (0.75, 1.25) | 0.806 |
Adjustments: age, smoking, diabetes, obesity (defined as BMI ≥ 30), systolic blood pressure, use of antihypertensive medications, plasma HDL-C, triglycerides, and LDL-C.
Hazard ratio is per 1 standard deviation.